A Phase 1 Study to Investigate the Safety and Tolerability of the Study Drug GB-0895 in Mild to Moderate Asthma Patients or Single Dose in Chronic Obstructive Pulmonary Disease (COPD)
GB-0895-101
Phase 1 other active
Quick answer
A Phase 1 Study to Investigate the Safety and Tolerability of the Study Drug GB-0895 in Mild to Moderate Asthma Patients or Single Dose in Chronic Obstructive Pulmonary Disease (COPD) for mild to moderate asthma, Chronic Obstructive Pulmonary Disease (COPD) is a Phase 1 program (other) at Generate Biomedicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Generate Biomedicines
- Indication
- mild to moderate asthma, Chronic Obstructive Pulmonary Disease (COPD)
- Phase
- Phase 1
- Modality
- other
- Status
- active